↓ Skip to main content

Interferon Beta for Primary Progressive Multiple Sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2010
Altmetric Badge

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interferon Beta for Primary Progressive Multiple Sclerosis
Published in
Cochrane database of systematic reviews, January 2010
DOI 10.1002/14651858.cd006643.pub3
Pubmed ID
Authors

Juan Ignacio Rojas, Marina Romano, Agustín Ciapponi, Liliana Patrucco, Edgardo Cristiano

Abstract

This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006643. DOI: 10.1002/14651858.CD006643.pub2).Therapeutic trials with ss-interferon in Multiple Sclerosis (MS) have mainly focused on remitting-relapsing multiple sclerosis (RRMS), demonstrating a reduction in relapse rate. However, there is not enough evidence about their efficacy in patients with primary progressive multiple sclerosis (PPMS).

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Italy 1 1%
United Kingdom 1 1%
Canada 1 1%
Spain 1 1%
Unknown 82 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 21%
Student > Master 13 15%
Student > Ph. D. Student 10 11%
Student > Bachelor 10 11%
Student > Doctoral Student 6 7%
Other 22 25%
Unknown 8 9%
Readers by discipline Count As %
Medicine and Dentistry 41 47%
Agricultural and Biological Sciences 9 10%
Neuroscience 6 7%
Nursing and Health Professions 6 7%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 10 11%
Unknown 12 14%